SQZ Biotechnologies Co — Form D

SQZ Biotechnologies Co of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-04. The offering totals $15.7M, of which $15.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Garry W NicholsonDirectorBoston, MA
Howard W BernsteinExecutive OfficerBoston, MA
Kris W ElverumExecutive OfficerBoston, MA
Robert LangerDirectorPittsburgh, PA
Armon ShareiDirectorArlington, MA
Armon ShareiExecutive OfficerArlington, MA
Jonathan FlemingDirectorCambridge, MA
Howard W Bernstein, M.D., Ph.D.Executive OfficerWatertown, MA
Oliver W Rosen, M.D.Executive OfficerWatertown, MA
David W FirstExecutive OfficerWatertown, MA
Armon Sharei, Ph.D.DirectorWatertown, MA
Armon Sharei, Ph.D.Executive OfficerWatertown, MA
Eric W MoessingerDirectorWatertown, MA
Alexandra W BalcomExecutive OfficerWatertown, MA
Teri W LoxamExecutive OfficerWatertown, MA
Pushkal W GargDirectorWatertown, MA
Marc W EliaDirectorWatertown, MA
Zafrira W AvnurDirectorWatertown, MA
Lawrence W KnopfExecutive OfficerWatertown, MA
Klavs F Jensen, Ph.D.DirectorWatertown, MA
Amy W SchulmanDirectorWatertown, MA
Amy W SchulmanExecutive OfficerWatertown, MA
Garry A NicholsonDirectorBaltimore, MD
Robert Langer, Sc.D.DirectorWatertown, MA
Marc A EliaDirectorWatertown, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-06-01D$70.2M$66.3M
2019-11-25D$71.3M
2016-12-01D/A$24.1M$24.1M
2015-07-28D/A$5.1M$5.1M
2015-06-30D$5.0M$5.0M
2014-04-03D$1.0M$15K

More